Abstract
Charcot–Marie–Tooth disease type 4C (CMT4C) is an autosomal recessive neuropathy caused by SH3TC2 mutations, characterized by spine deformities and cranial nerve involvement. This study identified four CMT4C families with compound heterozygous SH3TC2 mutations from 504 Korean demyelinating or intermediate CMT patients. The frequency of the CMT4C was calculated as 0.79% in demyelinating and intermediate patients (n = 504), but it was calculated as 2.02% in patients without PMP22 duplication (n = 198). The CMT4C frequency was similar to patients in Japan, but it was relatively low compared to those patients in other populations. The symptom was less severe and slowly progressed compared to the other AR-CMT. A patient harboring an intermediate neuropathy showed cranial nerve involvement but did not have scoliosis. This study will be helpful in making molecular diagnoses of demyelinating or intermediate CMT due to SH3TC2 mutations.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, De Jonghe P, et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot–Marie–Tooth type 4C neuropathy. Am J Hum Genet. 2003;73:1106–19.
Gooding R, Colomer J, King R, Angelicheva D, Marns L, Parman Y, et al. A novel Gypsy founder mutation, pArg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes. J Med Genet. 2005;42:e69.
Azzedine H, Ravise N, Verny C, Gabreels-Festen A, Lammens M, Grid D, et al. Spine deformities in Charcot–Marie–Tooth 4C caused by SH3TC2 gene mutations. Neurology . 2006;67:602–6.
Piscosquito G, Saveri P, Magri S, Ciano C, Gandioli C, Morbin M, et al. Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot–Marie–Tooth disease (CMT4). J Peripher Nerv Syst. 2016;21:142–9.
Rudnik-Schöneborn S, Tölle D, Senderek J, Eggermann K, Elbracht M, Kornak U, et al. Diagnostic algorithms in Charcot–Marie–Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin Genet. 2016;89:34–43.
Yuan JH, Hashiguchi A, Okamoto Y, Yoshimura A, Ando M, Shiomi K, et al. Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2. J Hum Genet. 2018;63:281–7.
Yger M, Stojkovic T, Tardieu S, Maisonobe T, Brice A, Echaniz-Laguna A, et al. Characteristics of clinical and electrophysiological pattern of Charcot–Marie–Tooth 4C. J Peripher Nerv Syst. 2012;17:112–22.
Arnaud E, Zenker J, de Preux Charles A-S, Stendel C, Roos A, Medard J-J, et al. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci USA. 2009;106:17528–33.
Roberts RC, Peden AA, Buss F, Bright NA, Latouche M, Reilly MM, et al. Mistargeting of SH3TC2 away from the recycling endosome causes Charcot–Marie–Tooth disease type 4C. Hum Mol Genet. 2010;19:1009–18.
Laššuthová P, Mazanec R, Vondráček P, Sišková D, Haberlová J, Sabová J, et al. High frequency of SH3TC2 mutations in Czech HMSN I patients. Clin Genet. 2011;80:334–45.
Kim SJ, Nam SH, Kanwal S, Nam DE, Yoo DH, Chae JH, et al. BAG3 mutation in a patient with atypical phenotypes of myofibrillar myopathy and Charcot–Marie–Tooth disease. Genes. Genomics . 2018;40:1269–77.
Nam SH, Hong YB, Hyun YS, Nam DE, Kwak G, Hwang SH, et al. Identification of genetic causes of inherited peripheral neuropathies by targeted gene panel sequencing. Mol Cells. 2016;39:382–8.
Nam DE, Yoo DH, Choi SS, Choi BO, Chung KW. Wide phenotypic spectrum in axonal Charcot–Marie–Tooth neuropathy type 2 patients with KIF5A mutations. Genes Genom. 2018;40:77–84.
Cipriani S, Phan V, Médard JJ, Horvath R, Lochmüller H, Chrast R, et al. Neuromuscular junction changes in a mouse model of Charcot–Marie–Tooth disease type 4C. Int J Mol Sci. 2018;19:pii: E4072.
DiVincenzo C, Elzinga CD, Medeiros AC, Karbassi I, Jones JR, Evans MC, et al. The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy. Mol Genet Genom Med. 2014;2:522–9.
Murphy SM, Herrmann DN, McDermott MP, Scherer SS, Shy ME, Reilly MM, et al. Reliability of the CMT neuropathy score (second version) in Charcot–Marie–Tooth disease. J Peripher Nerv Syst. 2011;16:191–8.
Acknowledgements
This work was supported by the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI14C3484 and HI16C0426) and by the National Research Foundation (2017R1A2A2A05001356, 2017R1A2B2004699, and 2018R1A4A1024506), Republic of Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Lee, A., Nam, S., Park, JM. et al. Compound heterozygous mutations of SH3TC2 in Charcot–Marie–Tooth disease type 4C patients. J Hum Genet 64, 961–965 (2019). https://doi.org/10.1038/s10038-019-0636-y
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s10038-019-0636-y
This article is cited by
-
Screening for SH3TC2 variants in Charcot–Marie–Tooth disease in a cohort of Chinese patients
Acta Neurologica Belgica (2022)
